Subgroup identification in clinical trials via the predicted individual treatment effect.
Subgroup identification in clinical trials via the predicted individual treatment effect.
复制标题
DOI:
10.1371/journal.pone.0205971
复制
发表时间:
2018
期刊:
影响因子:
3.7
通讯作者:
Posch M
中科院分区:
文献类型:
--
作者:
Ballarini NM;Rosenkranz GK;Jaki T;König F;Posch M
Identifying subgroups of treatment responders through the different phases of clinical trials has the potential to increase success in drug development. Recent developments in subgroup analysis consider subgroups that are defined in terms of the predicted individual treatment effect, i.e. the difference between the predicted outcome under treatment and the predicted outcome under control for each individual, which in turn may depend on multiple biomarkers. In this work, we study the properties of different modelling strategies to estimate the predicted individual treatment effect. We explore linear models and compare different estimation methods, such as maximum likelihood and the Lasso with and without randomized response. For the latter, we implement confidence intervals based on the selective inference framework to account for the model selection stage. We illustrate the methods in a dataset of a treatment for Alzheimer disease (normal response) and in a dataset of a treatment for prostate cancer (survival outcome). We also evaluate via simulations the performance of using the predicted individual treatment effect to identify subgroups where a novel treatment leads to better outcomes compared to a control treatment.
登录
查看更多内容
影响因子:
1.9
作者:
Li J;Zhao L;Tian L;Cai T;Claggett B;Callegaro A;Dizier B;Spiessens B;Ulloa-Montoya F;Wei LJ
通讯作者:
Wei LJ
影响因子:
1.9
作者:
Chen S;Tian L;Cai T;Yu M
通讯作者:
Yu M
影响因子:
17.3
作者:
Humpel, Christian
通讯作者:
Humpel, Christian
影响因子:
4.5
作者:
Lee, Jason D.;Sun, Dennis L.;Taylor, Jonathan E.
通讯作者:
Taylor, Jonathan E.
影响因子:
3.8
作者:
Arnold BF;van der Laan MJ;Hubbard AE;Steel C;Kubofcik J;Hamlin KL;Moss DM;Nutman TB;Priest JW;Lammie PJ
通讯作者:
Lammie PJ